Cargando…
Immunotherapy of Crohn's disease.
Although the initiating events of Crohn's disease are unknown, models of experimental colitis have provided new insights in the immunologically mediated pathways of mucosal inflammation. In Crohn's disease activated mucosal T lymphocytes produce proinflammatory cytokines within the mucosal...
Autores principales: | van Montfrans, C, Camoglio, L, van Deventer, S J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781847/ https://www.ncbi.nlm.nih.gov/pubmed/9705600 |
Ejemplares similares
-
Novel Microbial-Based Immunotherapy Approach for Crohn's Disease
por: Sutcliffe, Simon, et al.
Publicado: (2019) -
Infective Endocarditis as a Complication of Crohn’s Disease on Immunotherapy
por: Singh, Annapoorna, et al.
Publicado: (2022) -
Adalimumab in Crohn’s disease
por: Van Assche, Gert, et al.
Publicado: (2007) -
Assessing Disease Activity in Pediatric Crohn’s Disease Using Ultrasound: The Pediatric Crohn Disease Intestinal Ultrasound Score
por: van Wassenaer, Elsa A., et al.
Publicado: (2023) -
Crohn's disease--a case report.
por: Cho, K. J., et al.
Publicado: (1987)